Retrospective analysis of the clinical course of patients treated for polymyalgia

Open Access Rheumatology: Research and Reviews

Volumn 5, Issue , 2013, Pages 33-41

  Do Nguyen, Dung ^a   Inderjeeth, Charles A ^a,b,c   Edelman, Jack ^b   Cheah, Patrick ^b  

^a Grace McKellar Centre   (Australia)

^b SIR CHARLES GAIRDNER HOSPITAL   (Australia)

^c UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

Diagnosis; Polymyalgia rheumatica; Treatment

Indexed keywords

ALKALINE PHOSPHATASE; C REACTIVE PROTEIN; HEMOGLOBIN; PREDNISONE;

ADULT; AGED; ALKALINE PHOSPHATASE BLOOD LEVEL; COHORT ANALYSIS; DRUG EFFICACY; DRUG RESPONSE; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; HEMOGLOBIN BLOOD LEVEL; HUMAN; LIVER FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; POLYMYALGIA RHEUMATICA ACTIVITY SCORE; PROTEIN BLOOD LEVEL; REMISSION; RETROSPECTIVE STUDY; REVIEW; RHEUMATIC POLYMYALGIA; SCORING SYSTEM;

EID: 84876982429     PISSN: None     EISSN: 1179156X     Source Type: Journal    
DOI: 10.2147/OARRR.S38443     Document Type: Review

References (32)

1. Nothnagl T, Leeb B F. Diagnosis, differential diagnosis and treatment of polymyalgia rheumatica. Drugs Aging. 2004;23:391-402.
2. Inderjeeth C. Polymyalgia and giant cell arteritis. Med Today. 2009;10:57-60.
3. Cimmino MA, Zaccaria A. Epidemiology of polymyalgia rheumatica. Clin Exp Rheumatol. 2000;18(4 Suppl 20):S9-S11.
4. Weyand CM, Hunder NN, Hicok KC, et al. HLA-DRB1 alleles in polymyalgia rheumatica, giant cell arteritis, and rheumatoid arthritis. Arthritis Rheum. 1994;37:514-520.
5. Wagner AD, Gerard HC, Fresemann T, et al. Detection of Chlamydia pneumoniae in giant cell vasculitis and correlation with the topographic arrangement of tissue-infltrating dendritic cells. Arthritis Rheum. 2000;43:1543-1551.
6. Weyand CM, Hicok KC, Hunder GG, et al. Tissue cytokine patterns in patients with polymyalgia rheumatica and giant cell arteritis. Ann Intern Med. 1994;121:484-491.
7. Salvarani C, Cantini F, Hunder GG. Polymyalgia and giant-cell arteritis. Lancet. 2008;372:234-245.
8. Eamon M, Koening CL, Hoffman GS. Polymyalgia rheumatica and giant cell arteritis. Cleveland Clinic Online. Available from: http://www.clevelandclinicmeded.com. Accessed March 10, 2011.
9. Dasgupta B, Matteson EL, Maradit-Kremers H. Management guidelines and outcome measures in polymyalgia rheumatica (PMR). Clin Exp Rheumatol. 2007;25:130-136.
10. Dasgupta B. Concise guidance: diagnosis and management of polymy-algia rheumatica. Clin Med. 2010;10:270-274.
11. Brooks RC, McGee SR. Diagnostic dilemmas in polymyalgia rheumatica. Arch Intern Med. 1997;157:162-168.
12. Cantini F, Niccoli L, Nannini C, et al. Infammatory changes of hip synovial structures in polymyalgia rheumatica. Clin Exp Rheumatol. 2005;23:462-468.
13. Frediani B, Falsetti P, Storri L, et al. Evidence for synovitis in active polymyalgia rheumatica: sonographic study in a large series of patients. J Rheumatol. 2002;29:123-130.
14. Salvarani C, Cantini F, Oliveri I, et al. Polymyalgia rheumatica: a disorder of extraarticular synovial structures? J Rheumatol. 1999;26:517-521.
15. Cantini F, Salvarani C, Olivieri I, et al. Shoulder ultrasonography in a diagnosis of polymyalgia rheumatica: a case-control study. J Rheumatol. 2001;28:1049-1055.
16. Hunder GG. Clinical manifestations and diagnosis of polymyalgia rheumatica. Up-to-Date Online. Available from: http://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-polymyalgia-rheumatica. Accessed March 10, 2013.
17. Gonzalez-Gay MA, Agudo M, Martinez-Dubois O P, et al. Medical management of polymyalgia rheumatica. Expert Opin Pharmacother. 2010;11:1077-1087.
18. Hernandez-Rodriguez J, Espigol-Frigole G. Treatment of polymyalgia rheumatica a systematic review. Arch Intern Med. 2009;169: 1839-1850.
19. Barnes TC, Daroszewska A, Fraser WD, et al. Bone turnover in untreated polymyalgia rheumatic. Rheumatology. 2004;43:486-490.
20. Caporali R, Cimmino MA, Ferracciolo G, et al. Prednisone plus methotrexate in polymyalgia rheumatica: a randomized, double-blind, placebo-controlled trial. Ann Intern Med. 2004;141:493-500.
21. Leeb BF, Rintelen B, Sautner J, et al. The Polymyalgia Rheumatica Activity Score in daily use: proposal for a defnition of remission. Arthritis Rheum. 2007;57:810-815.
22. Leeb BF, Bird HA. A disease activity score for polymyalgia rheumatica. Ann Rheum Dis. 2004;63:1279-1283.
23. Silveira IG, Burlingame RW, Von Muhlen CA, et al. Anti-CCP antibodies have more diagnostic impact than rheumatoid factor (RF) in a population tested for RF. Clin Rheumatol. 2007;26:1883-1889.
24. Salvarani C, Cantini F, Niccoli L, et al. Acute-phase reactants and the risk of relapse/recurrence in polymyalgia rheumatica: a prospective followup study. Arthritis Rheum. 2005;53:33-38.
25. Corrigall VM, Dolan AL, Dasgupta B, et al. The sequential analysis of T lymphocyte subsets and interleukin-6 in polymyalgia rheumatica patients as predictors of disease remission and steroid withdrawal. Br J Rheumatol. 1997;36:976-980.
26. Hunder GG. Treatment of polymyalgia rheumatica. Up-to-Date Online. Available from: http://www.uptodate.com/contents/treatment-of-polymyalgia-rheumatica. Accessed March 10, 2013.
27. Kim H, Lee J, Ha Y, et al. Induction of remission is diffcult due to frequent relapse during tapering steroids in Korean patients with poly-myalgia rheumatica. J Korean Med Sci. 2012;27:22-26.
28. Dejaco C, Duftner C, Cimmino MA, et al. Defnition of remission and relapse in polymyalgia rheumatica: data from a literature search compared with a Delphi-based expert consensus. Ann Rheum Dis. 2011;70:447-453.
29. Migliore A, Massafra U, Carloni E, et al. TNF-alpha blockade induce clinical remission in patients affected by polymyalgia rheumatic associated to diabetes mellitus and/or osteoporosis: a seven case report. Eur Rev Med Pharmacol Sci. 2005;9:373-378.
30. Salvarani C, Macchioni P, Manzini C, et al. Infiximab plus prednisone or placebo plus prednisone for the initial treatment of polymyalgia rheumatica: a randomized trial. Ann Intern Med. 2007;146:631-639.
31. Kreiner F, Galbo H. Effect of etanercept in polymyalgia rheumatica: a randomized controlled trial. Arthritis Res Ther. 2010;12:R176.
32. Rovensky J, Tuchynova A. Polymyalgia, temporal arteritis and occurrence of malignant tumours. Preliminary report of 26 patients with PMR and TA being followed prospectively. Cancer and Autoimmunity. 2000:81-83.